Actos, the Latest of the Diabetes Fighters

Actos, released this summer by Lilly and Co. in collaboration with Takeada Pharmaceuticals, is the latest of the oral agents for treatment of diabetes. Actos whose chemical name is pioglitazone, is part of the new class of diabetes fighting drugs called “glitazones”. Other drugs in this class are Rezulin(Parke Davis/Sankyo) and Avandia (Bristol Myers Squibb). [...]

Old News About Avandia and Actos Makes the Front Page NY Times

Today’s NY Times carries a front page article about the dangers of Actos and Avandia, two popular diabetes medications. The reason behind the news story is that the FDA has finally required the two companies that make these diabetes drugs to carry a “black box” warning (the strongest labeling warning that can be applied) about [...]